You have 9 free searches left this month | for more free features.

Chronic Lymphocytic Leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
    • Bobigny, France
    • +8 more
    Mar 23, 2022

    ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
      • (no location specified)
      May 7, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

      Recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +4 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Mar 22, 2022

      Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Stage I Chronic Lymphocytic Leukemia
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Mar 24, 2022

      Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 15, 2022

      Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

      Terminated
      • Small Lymphocytic Leukemia (SLL)
      • Chronic Lymphocytic Leukemia (CLL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 15, 2022

      Chronic Lymphocytic Leukemia (CLL) Trial

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
        • (no location specified)
        Apr 5, 2022

        Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

        Not yet recruiting
        • Recurrent Chronic Lymphocytic Leukemia
        • +3 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        May 20, 2022

        Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Feb 23, 2022

        Chronic Lymphocytic Leukemia Stage A(0), Chronic Lymphocytic Leukemia Stage A(I), Chronic Lymphocytic Leukemia Stage A(II) Trial

        Recruiting
        • Chronic Lymphocytic Leukemia Stage A(0)
        • +3 more
        • Low Dose Selenious Yeast Tablets
        • High Dose Selenious Yeast Tablets
        • Shanghai, Shanghai, China
          Zhongshan Hospital
        Nov 26, 2021

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Pneumococcal 13-valent Conjugate Vaccine
        • Pneumococcal Polyvalent Vaccine
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Jun 9, 2022

        Venetoclax in Patients With Chronic Lymphocytic Leukemia

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Taipei, Taiwan
          National Taiwan University Hospital
        Oct 27, 2021

        Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Questionnaire Administration
        • Ruxolitinib Phosphate
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 2, 2022

        Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +3 more
        • Whittier, California
          Innovative Clinical Research Institute
        Aug 8, 2022

        Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

        Withdrawn
        • Chronic Lymphocytic Leukemia
        • +8 more
        • Dose combination 1-1
        • +5 more
        • (no location specified)
        Nov 1, 2021

        Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

        Active, not recruiting
        • Contiguous Stage II Small Lymphocytic Lymphoma
        • +11 more
        • MOR00208
        • +2 more
        • Columbus, Ohio
          The Ohio State University Comprehensive Cancer Center
        Feb 24, 2022

        Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

        Completed
        • CLL
          • Tampere, Finland
            Tampere university Hospital
          Feb 22, 2022

          Chronic Lymphocytic Leukemia Trial in Columbus, Hermitage, Fort Worth (acalabrutinib, ACP-319)

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
          • Columbus, Ohio
          • +1 more
          Jan 20, 2022

          Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

          Completed
          • Loss of Chromosome 17p
          • +5 more
          • Houston, Texas
            M D Anderson Cancer Center
          Mar 4, 2022

          Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Leukemia
          • (no location specified)
          Nov 14, 2022

          Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

          Not yet recruiting
          • Hematopoietic and Lymphoid Cell Neoplasm
          • +5 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jul 10, 2022

          Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

          Recruiting
          • Relapsed Non Hodgkin Lymphoma
          • +6 more
          • Cincinnati, Ohio
          • +4 more
          Aug 3, 2022

          Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

          Recruiting
          • Recurrent Chronic Lymphocytic Leukemia
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 17, 2022

          Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • [U-13C]glucose
          • [13C5]glutamine
          • Madison, Wisconsin
            University of Wisconsin
          Jun 15, 2022